Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest
- 30 May 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 40 (35) , 2953-2961
Abstract
Aims: In patients with catecholaminergic polymorphic ventricular tachycardia (CPVT), implantable cardioverter-defibrillator (ICD) shocks are sometimes ineffective and may even trigger fatal electrical storms. We assessed the efficacy and complications of ICDs placed in patients with CPVT who presented with a sentinel event of sudden cardiac arrest (SCA) while undiagnosed and therefore untreated. Methods and results: We analysed 136 patients who presented with SCA and in whom CPVT was diagnosed subsequently, leading to the initiation of guideline-directed therapy, including β-blockers, flecainide, and/or left cardiac sympathetic denervation. An ICD was implanted in 79 patients (58.1%). The primary outcome of the study was sudden cardiac death (SCD). The secondary outcomes were composite outcomes of SCD, SCA, appropriate ICD shocks, and syncope. After a median follow-up of 4.8 years, SCD had occurred in three patients (3.8%) with an ICD and none of the patients without an ICD (P = 0.1). SCD, SCA, or appropriate ICD shocks occurred in 37 patients (46.8%) with an ICD and 9 patients (15.8%) without an ICD (P < 0.0001). Inappropriate ICD shocks occurred in 19 patients (24.7%) and other device-related complications in 22 patients (28.9%). Conclusion: In previously undiagnosed patients with CPVT who presented with SCA, an ICD was not associated with improved survival. Instead, the ICD was associated with both a high rate of appropriate ICD shocks and inappropriate ICD shocks along with other device-related complications. Strict adherence to guideline-directed therapy without an ICD may provide adequate protection in these patients without all the potential disadvantages of an ICD.Keywords
Funding Information
- ZonMW Priority Medicines for Rare Diseases and Orphan Drugs (113304045)
- National Health and Medical Research Council
- NHMRC (1059156)
- Mayo Clinic Windland Smith Rice Comprehensive Sudden Cardiac Death Program
- Netherlands Federation of University Medical Centres
- Netherlands Organisation for Health Research and Development
- Royal Netherlands Academy of Sciences (CVON 2012-10 PREDICT)
- E-Rare Joint Transnational Call for Proposals 2015 ‘Improving Diagnosis and Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: Integrating Clinical and Basic Science’
This publication has 22 references indexed in Scilit:
- Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardiaHeart Rhythm, 2013
- Familial Evaluation in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation: Arrhythmia and Electrophysiology, 2012
- Importance of Ventricular Tachycardia Storms Not Terminated by Implantable Cardioverter Defibrillators Shocks in Patients With CASQ2 Associated Catecholaminergic Polymorphic Ventricular TachycardiaThe American Journal of Cardiology, 2012
- Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardiaHeart Rhythm, 2011
- Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular TachycardiaJACC, 2011
- Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular TachycardiaCirculation, 2009
- Left Cardiac Sympathetic Denervation for Catecholaminergic Polymorphic Ventricular TachycardiaNew England Journal of Medicine, 2008
- Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardiaHeart Rhythm, 2006
- Tormenta arrítmica inducida por descargas del desfibrilador automático implantable en una taquicardia ventricular polimórfica catecolaminérgicaRevista Espanola de Cardiologia, 2006
- Catecholaminergic Polymorphic Ventricular Tachycardia in ChildrenCirculation, 1995